Stryker Case Analysis

1149 Words5 Pages

Stryker is one of the world's leading medical technology companies and, together with our customers, they are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world. Stryker’s history is rooted in innovation. When Dr. Homer Stryker, an orthopaedic surgeon from Kalamazoo, Michigan, found that certain medical products were not meeting his patients’ needs, he invented new ones. As interest in these products grew, Dr. Stryker started a company in 1941 to produce them. The company’s goal was to help patients lead healthier, …show more content…

Trauson, their first acquisition Stryker was a leading maker of specialty medical and surgical products, a market expected to show strong sales growth. Stryker marketed its products directly to hospitals and physicians in the United States and 100 other countries. Given the decline in the number of hospitals due to consolidation and cost containment efforts by government programs and health care insurers, the industry expected continued downward pressure on prices. How could Stryker effectively deal with these developments to continue its growth? (Thomas L, 2010) One key reason for their success is the decentralized manner in which we operate our businesses. Division presidents have direct responsibility for Sales, Marketing, R&D and Business Development. They are laser-focused on their customers’ needs, and their teams’ entrepreneurial spirit drives sustained, high growth. Specialized sales forces, with drive and passion, continue to be a core strength at …show more content…

If a company sticks to what it knows and does, best then the likelihood of business success increases. For Stryker’s businesses and product lines, this seems mostly true.

If we view Stryker as having two primary businesses and sources of review. They have stuck very closely to orthopedic joint replacements/implants and medical/surgical equipment. In the instance where they did invest outside of the core competency (i.e. Stryker Biotech), they have gotten in trouble with the Department of Justice. Stryker Biotech produces a bone growth product and the DOJ is investigating Stryker Biotech for marketing off-label usage of the product. I expect that Stryker will look to settle this lawsuit as quickly as possible, and the current effect on their stock price could present an opportunity.

Other areas of Stryker’s business include ten discrete operating divisions: Howmedica Osteonics; Stryker Endoscopy; Stryker Instruments; Stryker Medical; Physiotherapy Associates; Stryker Pacific; Stryker Europe; Matsumoto Medical Instruments; Stryker Americas; and Stryker Biotech. For the most part, however, Stryker has stuck pretty close to their core